Histone deacetylase inhibitor entinostat reverses epithelial to mesenchymal transition of breast cancer cells by reversing the repression of E-cadherin
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Histone deacetylase inhibitor entinostat reverses epithelial to mesenchymal transition of breast cancer cells by reversing the repression of E-cadherin
Authors
Keywords
Epithelial to mesenchymal transition, E-cadherin, HDAC inhibitor
Journal
BREAST CANCER RESEARCH AND TREATMENT
Volume 143, Issue 1, Pages 99-111
Publisher
Springer Nature
Online
2013-12-04
DOI
10.1007/s10549-013-2784-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- E-cadherin promotor methylation and mutation are inversely related to motility capacity of breast cancer cells
- (2012) Remco van Horssen et al. BREAST CANCER RESEARCH AND TREATMENT
- Functional Activation of the Estrogen Receptor- and Aromatase by the HDAC Inhibitor Entinostat Sensitizes ER-Negative Tumors to Letrozole
- (2011) G. J. Sabnis et al. CANCER RESEARCH
- Vimentin in cancer and its potential as a molecular target for cancer therapy
- (2011) Arun Satelli et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Differential roles of Src in transforming growth factor-ß regulation of growth arrest, epithelial-to-mesenchymal transition and cell migration in pancreatic ductal adenocarcinoma cells
- (2011) Ungefroren INTERNATIONAL JOURNAL OF ONCOLOGY
- Epithelial-to-Mesenchymal Transition Promotes Tubulin Detyrosination and Microtentacles that Enhance Endothelial Engagement
- (2010) R. A. Whipple et al. CANCER RESEARCH
- Metastatic breast tumors express increased tau, which promotes microtentacle formation and the reattachment of detached breast tumor cells
- (2010) M A Matrone et al. ONCOGENE
- Vimentin regulates EMT induction by Slug and oncogenic H-Ras and migration by governing Axl expression in breast cancer
- (2010) K Vuoriluoto et al. ONCOGENE
- Molecular mechanisms controlling E-cadherin expression in breast cancer
- (2009) Somesh Baranwal et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Trastuzumab Reverses Letrozole Resistance and Amplifies the Sensitivity of Breast Cancer Cells to Estrogen
- (2009) Gauri Sabnis et al. CANCER RESEARCH
- Motor-dependent microtubule disassembly driven by tubulin tyrosination
- (2009) Leticia Peris et al. JOURNAL OF CELL BIOLOGY
- Epigenetic silencing in non-neoplastic epithelia identifies E-cadherin (CDH1) as a target for chemoprevention of lobular neoplasia
- (2009) Donghui Zou et al. JOURNAL OF PATHOLOGY
- Vimentin Filaments Support Extension of Tubulin-Based Microtentacles in Detached Breast Tumor Cells
- (2008) R. A. Whipple et al. CANCER RESEARCH
- The cell-cell adhesion molecule E-cadherin
- (2008) F. van Roy et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Epithelial mesenchymal transition traits in human breast cancer cell lines
- (2008) T. Blick et al. CLINICAL & EXPERIMENTAL METASTASIS
- Twist is a transcriptional repressor of E-cadherin gene expression in breast cancer
- (2007) Farhad Vesuna et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now